Because loss of serotoninergic neuronal perikarya is well documented in post-mortem studies of PD participants, attributing differences in SERT binding to differential loss of serotoninergic neurons and terminals is the most parsimonious explanation for differences in regional [11C]DASB binding in our participants [26], [58], [59]. This evidence concerns the gene SLC6A4 and Parkinson disease.